Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective

Starting soon

Conditions studied: Atopic Dermatitis, Eczema Atopic Dermatitis, Eczema, Caregiver, Burden

In brief

This study will address this gap by providing comprehensive data on disease burden from a caregiver perspective in a Canadian population, ultimately supporting improved clinical decision-making and healthcare resource allocation.

Key facts

Study ID

NCT07323394

Run by

PeriPharm

People needed

100

Starts

2026-01-01

Expected to finish

2026-07-01

Last updated by the study team

2026-01-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Aged ≥18 years;
• Caregiver of a child aged ≥2 to ≤11 years with mild to moderate atopic dermatitis;
• Able to read and understand French or English;
• Willing and able to provide written informed consent.

You may not qualify if…

• Caregivers whose child has been diagnosed with severe atopic dermatitis ;
• Caregivers whose child is currently treated with oral or topical Janus Kinase Inhibitor);
• Caregivers whose child is currently participating in a clinical trial for atopic dermatitis;
• Other parent or caregiver within the household of the child with atopic dermatitis.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.